Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2024-11-26

FDA Approved: LEVETIRACETAM — Supplemental Application (ScieGen Pharmaceuticals, Inc.)

View source ↗

Summary

FDA lists a supplemental application for levetiracetam by ScieGen Pharmaceuticals, Inc. under an approved ANDA; the specific change being requested is not discl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM (levetiracetam)

Snippet

SUPPL AP for LEVETIRACETAM (LEVETIRACETAM)